To view this email as a web page, click here.

Pediatrics
Gene therapy trial for blistering skin condition advancing to next stage
FCX-007 could be the first major medical advance for recessive dystrophic epidermolysis bullosa, or RDEB, in decades.
Read more.
ADVERTISEMENT
 
Pediatric psoriasis research collaboration
A global community of physicians cooperated to share experiences with systemic drugs for pediatric psoriasis and to get experience with a joint registry. A uniform dataset could be tapped to learn more about disease manifestations and treatment outcomes.
Read more.
ADVERTISEMENT
 
JOB OPPORTUNITIES
 
 
ADVERTISEMENT
Is your tech saving your practice money?
In the new world of value-based care, technology matters. This whitepaper plugs you into Cloud-based solutions that can help improve clinical outcomes — and transform healthcare IT from a distraction into an advantage. Read the whitepaper now. »
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.